Comparison of efficacy and safety of oral ivermectin with topical permethrin in treatment of scabies

Authors

  • Aisha Mushtaq
  • Khawar Khurshid
  • Sabrina Suhail Pal

Keywords:

Scabies, permethrin, ivermectin

Abstract

Background Scabies is an ectoparasitic, highly contagious skin disease caused by a mite called Sarcoptes scabiei. Topical permethrin and oral ivermectin are currently being used and considered to be safe and effective than the previously used agents. Objective To compare the efficacy and safety of oral ivermectin with topical permethrin in treating scabies. Patients and methods It was an interventional (quasi-experimental) study, conducted in out-patient clinic of Dermatology Department, Unit II, Mayo Hospital, Lahore. Hundred patients belonging to either sex and from 2 to 60 years of age were divided into two groups. Oral ivermectin was given to group A in a single dose of 200 µg/kg body weight. Group B was given single application of topical permethrin 5% cream at night on whole body for 12 hours. When there was no cure in two weeks, a 2nd treatment was given with either drug in their respective group. Investigations were carried out at presentation and at 2nd week while patients were followed up at 2nd and 4th weeks. Results Permethrin showed marginal better efficacy (88.1%) in completely clearing scabietic lesions at fourth week of therapy as compared to ivermectin (79.5%), the difference was insignificant (p=0.15). Seven patients in ivermectin group had side effects as headache, increase in itching and secondary bacterial infections as compared to permethrin group in which one patient had erythema (p<0.05).  Conclusion Ivermectin is as effective as permethrin in the treatment of scabies when used in two doses over a period of 4 weeks. 

References

Binder WD, Sciammarella J, Scabies [Online] 2006 [cited 2008 Dec 12]; Available from: URL: http://emedicine.medscape.com/article/785873

Burrs DA. Diseases caused by arthropods and other noxious animals. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s Textbook of Dermatology. Blackwell Science; 2004. P. 39.42.

Orkin M, Maibach HI. Scabies and pediculosis. In: Freedberg ZIM, Eisen AZ, Wolff K et al., eds. Fitzpatrick's Dermatology in General Medicine, 5lh edn. New York: McGraw-Hill; 1999. P. 2677- 84.

Walker GJA, Johnstone PW. Interventions for treating scabies (Cochrane review). 2002; 4. Available from: http://www.update-software.com/ abstracts/ab000320.htm.)

Buffet M, Dupin N. Current treatments for scabies. Fundam Clin Pharmacol 2003; 17: 217-25.

Roos TC, Alam M, Roos S et al. Pharmacotherapy of ectoparasitic infections. Drugs 2001; 61: 1067-88.

Del Guidice P. Ivermectin in scabies. Curr Opin Infec Dis 2002; 15: 123-6.

Scabies [online] 2007 [cited 2008 May 14]. Available from; URL: http://www.stanford.edu/class/humbio103/ParaSites2004/Scabies/Scabies20Home.htm#Introduction.

Paasch U, Haustein UF. Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. Int J Dermatol 2000; 39: 463-70.

Santoro AF, Rezac MA, Lee JB. Current trend in ivermectin usage for scabies. J Drugs Dermatol 2003; 2: 397-401.

Usha V, Gopalakrishnan-Nair TV. A Comparative study of oral ivermectin and topical permethrin creams in treatment of scabies. J Am Acad Dermatol 2000; 42: 236-40.

Shan Q, Haddrill JL, Lynch JW. Ivermectin, an unconventional agonist of the glycine receptor chloride channel. J Biol Chem 2001; 276: 556-64.

Akhtar SJ, Maan MA, Iqbal J, Kapadia N. Treatment of scabies simplified. J Pak Assoc Dermatol 2007; 17: 240-9.

Temple WA, Smith NA. Ivermectin [Online] 2003 [cited 2007 Sept 02]. Available from; http://www.inchem.org/documents/pims/pharm/ivermect.htm.

Elgart GW, Meinking TL. Ivermectin. Dermatol Clin 2003; 21: 277-82.

Khan I, Yasmin R. Ivermectin in the treatment of scabies. J Pak Assoc Dermatol 2007; 17: 78-83.

Haas N, Lindemann U, Frank K et al. Rapid and preferential sebum secretion of ivermectin: a new factor that may determine drug responsiveness in patients with scabies. Arch Dermatol 2002; 138: 1618-9.

Teichmann A, Martschick A, Jacobi U et al. Drug delivery of systemically applied substances into the skin: the hypothesis of inverse penetration. [Online] 2004 [cited on Dec 2008]; Available from: http://www.aapsj.org/abstracts/AM_2006/AAPS2006-001433.pdf

Downloads

Published

2016-12-21

How to Cite

1.
Mushtaq A, Khurshid K, Pal SS. Comparison of efficacy and safety of oral ivermectin with topical permethrin in treatment of scabies. J Pak Assoc Dermatol [Internet]. 2016Dec.21 [cited 2024Nov.8];20(4):227-31. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/382

Issue

Section

Original Articles

Most read articles by the same author(s)

1 2 3 4 > >>